A mechanism-based pharmacokinetic/pharmacodynamic (PK/PD) model for omalizumab (rhuMAb-E25).

被引：0
|
作者：
Sun, YN [1 ]
Marian, M [1 ]
Schoenhoff, M [1 ]
Sinclair, D [1 ]
Fick, R [1 ]
机构：
[1] Genentech Inc, S San Francisco, CA 94080 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P87 / P87
页数：1
相关论文
共 50 条
  • [1] The role of omalizumab or rhuMAb-E25 in the treatment of allergic rhinitis
    Lee, DKC
    EUROPEAN RESPIRATORY JOURNAL, 2004, 24 (02) : 330 - 330
  • [2] Omalizumab (rhuMAb-E25) - A recombinant humanized monoclonal antibody for the treatment of refractory asthma
    Self, TH
    James, AW
    Finch, CK
    FORMULARY, 2001, 36 (08) : 571 - +
  • [3] Therapy of allergic diseases by omalizumab (Xolair, rhuMab-E25, anti-IgE)
    Beeh, KM
    Buhl, R
    ALLERGOLOGIE, 2002, 25 (09) : 497 - 501
  • [4] Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research
    Danhof, Meindert
    de Lange, Elizabeth C. M.
    Della Pasqua, Oscar E.
    Ploeger, Bart A.
    Voskuyl, Rob A.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2008, 29 (04) : 186 - 191
  • [5] Incorporating Receptor Theory in Mechanism-Based Pharmacokinetic-Pharmacodynamic (PK-PD) Modeling
    Ploeger, Bart A.
    van der Graaf, Piet H.
    Danhof, Meindert
    DRUG METABOLISM AND PHARMACOKINETICS, 2009, 24 (01) : 3 - 15
  • [6] The role of mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modelling in translational research of biologics
    Agoram, Balaji M.
    Martin, Steven W.
    van der Graaf, Piet H.
    DRUG DISCOVERY TODAY, 2007, 12 (23-24) : 1018 - 1024
  • [7] Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling and simulation of oxaliplatin for hematological toxicity in rats
    Kobuchi, Shinji
    Katsuyama, Yosuke
    Ito, Yukako
    XENOBIOTICA, 2020, 50 (02) : 146 - 153
  • [8] Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates
    Sukumaran, Siddharth
    Gadkar, Kapil
    Zhang, Crystal
    Bhakta, Sunil
    Liu, Luna
    Xu, Keyang
    Raab, Helga
    Yu, Shang-Fan
    Mai, Elaine
    Fourie-O'Donohue, Aimee
    Kozak, Katherine R.
    Ramanujan, Saroja
    Junutula, Jagath R.
    Lin, Kedan
    PHARMACEUTICAL RESEARCH, 2015, 32 (06) : 1884 - 1893
  • [9] Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates
    Siddharth Sukumaran
    Kapil Gadkar
    Crystal Zhang
    Sunil Bhakta
    Luna Liu
    Keyang Xu
    Helga Raab
    Shang-Fan Yu
    Elaine Mai
    Aimee Fourie-O’Donohue
    Katherine R. Kozak
    Saroja Ramanujan
    Jagath R. Junutula
    Kedan Lin
    Pharmaceutical Research, 2015, 32 : 1884 - 1893
  • [10] A new pharmacokinetic/pharmacodynamic model (PK/PD) for mivacurium
    Laurin, J
    Nekka, F
    Donati, F
    Varin, F
    ANESTHESIOLOGY, 1996, 85 (3A) : A323 - A323
12345